Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer

ABSTRACT Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs ha...

Full description

Bibliographic Details
Main Authors: Haiyang Zhang, Jingjing Duan, Yanjun Qu, Ting Deng, Rui Liu, Le Zhang, Ming Bai, Jialu Li, Tao Ning, Shaohua Ge, Xia Wang, Zhenzhen Wang, Qian Fan, Hongli Li, Guoguang Ying, Dingzhi Huang, Yi Ba
Format: Article
Language:English
Published: Oxford University Press 2016-01-01
Series:Protein & Cell
Subjects:
Online Access:http://link.springer.com/article/10.1007/s13238-015-0234-5
_version_ 1797725988997562368
author Haiyang Zhang
Jingjing Duan
Yanjun Qu
Ting Deng
Rui Liu
Le Zhang
Ming Bai
Jialu Li
Tao Ning
Shaohua Ge
Xia Wang
Zhenzhen Wang
Qian Fan
Hongli Li
Guoguang Ying
Dingzhi Huang
Yi Ba
author_facet Haiyang Zhang
Jingjing Duan
Yanjun Qu
Ting Deng
Rui Liu
Le Zhang
Ming Bai
Jialu Li
Tao Ning
Shaohua Ge
Xia Wang
Zhenzhen Wang
Qian Fan
Hongli Li
Guoguang Ying
Dingzhi Huang
Yi Ba
author_sort Haiyang Zhang
collection DOAJ
description ABSTRACT Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3′UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.
first_indexed 2024-03-12T10:39:14Z
format Article
id doaj.art-0280cb420bcc4b2fa20295ad0924f43e
institution Directory Open Access Journal
issn 1674-800X
1674-8018
language English
last_indexed 2024-03-12T10:39:14Z
publishDate 2016-01-01
publisher Oxford University Press
record_format Article
series Protein & Cell
spelling doaj.art-0280cb420bcc4b2fa20295ad0924f43e2023-09-02T08:20:11ZengOxford University PressProtein & Cell1674-800X1674-80182016-01-017214115110.1007/s13238-015-0234-5Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancerHaiyang Zhang0Jingjing Duan1Yanjun Qu2Ting Deng3Rui Liu4Le Zhang5Ming Bai6Jialu Li7Tao Ning8Shaohua Ge9Xia Wang10Zhenzhen Wang11Qian Fan12Hongli Li13Guoguang Ying14Dingzhi Huang15Yi Ba16Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerDepartment of Gastroenterology, Tianjin First Center HospitalTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerChangchun GeneScience Pharmaceuticals Co., LtdTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerTianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for CancerABSTRACT Gastric cancer is one of the most common malignancies worldwide; however, the molecular mechanism in tumorigenesis still needs exploration. BCL2L11 belongs to the BCL-2 family, and acts as a central regulator of the intrinsic apoptotic cascade and mediates cell apoptosis. Although miRNAs have been reported to be involved in each stage of cancer development, the role of miR-24 in GC has not been reported yet. In the present study, miR-24 was found to be up-regulated while the expression of BCL2L11 was inhibited in tumor tissues of GC. Studies from both in vitro and in vivo shown that miR-24 regulates BCL2L11 expression by directly binding with 3′UTR of mRNA, thus promoting cell growth, migration while inhibiting cell apoptosis. Therefore, miR-24 is a novel onco-miRNA that can be potential drug targets for future clinical use.http://link.springer.com/article/10.1007/s13238-015-0234-5gastric cancerBCL2L11miR-24tumorigenesiscell apoptosisproliferation
spellingShingle Haiyang Zhang
Jingjing Duan
Yanjun Qu
Ting Deng
Rui Liu
Le Zhang
Ming Bai
Jialu Li
Tao Ning
Shaohua Ge
Xia Wang
Zhenzhen Wang
Qian Fan
Hongli Li
Guoguang Ying
Dingzhi Huang
Yi Ba
Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
Protein & Cell
gastric cancer
BCL2L11
miR-24
tumorigenesis
cell apoptosis
proliferation
title Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
title_full Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
title_fullStr Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
title_full_unstemmed Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
title_short Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
title_sort onco mir 24 regulates cell growth and apoptosis by targeting bcl2l11 in gastric cancer
topic gastric cancer
BCL2L11
miR-24
tumorigenesis
cell apoptosis
proliferation
url http://link.springer.com/article/10.1007/s13238-015-0234-5
work_keys_str_mv AT haiyangzhang oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT jingjingduan oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT yanjunqu oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT tingdeng oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT ruiliu oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT lezhang oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT mingbai oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT jialuli oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT taoning oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT shaohuage oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT xiawang oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT zhenzhenwang oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT qianfan oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT honglili oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT guoguangying oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT dingzhihuang oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer
AT yiba oncomir24regulatescellgrowthandapoptosisbytargetingbcl2l11ingastriccancer